Supporting I–O combination therapy development with correlative assays & biomarker discovery

Abi Pinchbeck, Assistant Editor, Immuno-Oncology Insights, speaks to (pictured left to right) Ana Rosa Saez-Ibanez and Samik Upadhaya from the Cancer Research Institute, about their research in combination therapies across the I–O landscape and the importance of implementation of correlative assays in combination clinical trials.

Please enter your email to access content Read now